Metabolic syndrome: Evaluation of pathological and therapeutic outcomes
Open Access
- 1 January 2005
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 149 (1), 20-32
- https://doi.org/10.1016/j.ahj.2004.07.012
Abstract
No abstract availableThis publication has 91 references indexed in Scilit:
- Metabolic syndrome: Definition, pathophysiology, and mechanismsAmerican Heart Journal, 2005
- Inflammation in atherosclerosisNature, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Leptin-Replacement Therapy for LipodystrophyNew England Journal of Medicine, 2002
- Metabolic and Additional Vascular Effects of ThiazolidinedionesDrugs, 2002
- Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysisThe Lancet, 2001
- Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populationsThe American Journal of Cardiology, 2000
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐upJournal of Internal Medicine, 1994
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987